Study | Study type | Study period | Study group | Province- City | Sample size | Evaluated drugs | Successful sequences | Quality score (out of 9) |
---|---|---|---|---|---|---|---|---|
Marjani 2020 [12] | Cross-sectional | June 2012 to December 2018 | People receiving ART | Tehran | 655 | Integrase region | 62 | 9 |
Bokharaei, 2020 [13] | Cross-sectional | April 2013 to September 2018 | People receiving ART, ART naïve | Tehran | 60 naïve, 592 people receiving ART | NRTI, NNRTI, and PI | 60 | 9 |
Mohraz, 2019 [14] | Cross-sectional | December 2015 and May 2016 | People receiving ART | 11 Cities (Tehran, Qom, Esfahan, Gilan, Kermanshah, Ahvaz, Bandar Abbas, Khorramabad, Karaj, Kerman, Hamedan) | 207 | NRTI, NNRTI, and PI | 78 | 9 |
Memarnejadian, 2019 [15] | Cross-sectional | April 2016 to March 2017 | People receiving ART | Bandar Abbas | 44 | NRTI, NNRTI, and PI | 44 | 6 |
Farrokhi, 2019 [16] | Cross-sectional |  | ART naïve | Tehran, Kermanshah, Esfahan, Shiraz, Mashhad, Gilan, Bandar Abbas, Ahvaz | 105 | NRTI, NNRTI, and PI | 90 | 7 |
Nasiri-Tajabadi, 2018 [17] | Cross-sectional |  | People receiving ART, ART naïve | Tehran, Mashhad | 25 25 | PI | 25 25 | 6 |
Memarnejadian, 2018 [18] | Cross sectional | April 2016 and March 2017 | ART naïve | Bandar Abbas | 41 | NRTI, NNRTI, and PI | 41 | 9 |
Ghafari, 2018 [19] | Cross-sectional | March 2014 to February 2015 | ART naïve | Ahvaz | 52 | NRTI, NNRTI, and PI | 52 | 5 |
Vahabpour, 2017 [20] | Cross-sectional | September 2015 and July 2016 | ART naïve | Tehran | 42 | NRTI, NNRTI, and PI | 42 | 9 |
Farrokhi [21] | Cross-sectional |  | People receiving ART, ART naïve | Tehran | 50 28 | NRTI, NNRTI, and PI | 50 28 | 6 |
Naziri, 2016 [22] | Cross-sectional | April 2013 to February 2014 | People receiving ART, ART naïve | Shiraz | 62 40 | NRTI, NNRTI, and PI | 62 40 | 6 |
Baesi, [23] | Cross-sectional | Â | People receiving ART | Tehran | 25 | PI | 25 | 5 |
Memarnejadian, 2015 [24] | Cross sectional | 2011 | ART- naïve | Sanandaj | 40 | NRTI, NNRTI, and PI | 40 | 9 |
Gol Mohammadi, 2015 [25] | Cross-sectional | Â | People receiving ART | Gorgan | 130 | NRTI and NNRTI | 122 | 6 |
Baesi, 2014 [26] | Cross-sectional |  | People receiving ART, ART- naïve | Tehran | 70 30 | NRTI, NNRTI, and PI | 62 62 | 9 |
Jahanbakhsh, 2013 [27] | Cross-sectional | January 2010 to February 2011 | ART- naïve | Tehran, Kermanshah and Shiraz | 50 | NRTI, NNRTI, and PI | 47 | 9 |
Baesi, 2012 [28] | Cross-sectional |  | ART- naïve People receiving ART | Tehran | 30 16 | PI | 30 15 | 6 |
Baesi, 2012 [29] | Cross-sectional | Â | People receiving ART | Tehran | 25 | NRTI and NNRTI | 24 | 6 |
Naziri, 2013 [30] | Cross-sectional | Not reported | People receiving ART, ART naïve | Shiraz | 20 20 | NRTI, NNRTI, and PI | 20 20 | 5 |
Hamkar, 2010 [31] | Cross-sectional | Â | People receiving ART | Tehran | 42 | NRT, NNRTI, and PI | 42 | 9 |
Gholami, 2020 [32] | Cross-sectional | Â | People receiving ART | Tehran, Khorramabad, Qom, Ahvaz, and Hamedan | 41 | NNRTI, NNRT, PI, and INTI | 41 | 6 |
Mousavi, 2010 [33] | Cross-sectional | Â | People receiving ART | Tehran, Khorramabad, Ahvaz, Qom, Hamedan | 33 | NRT, NNRTI, PI, and INIs | Â | 9 |